… neutralizes SARS-CoV2 viruses Next, we investigated the neutralization ability of W25 against
two clinical isolates of … W25 demonstrated strong neutralizing activity with IC50 values of …

… circulating primary HIV-1 isolates derived … potency against clinical isolates produced in
PBMCs than against Env-pseudotyped viruses. The magnitude of this difference in neutralizing …

… In conclusion, the present study explored the breadth of reactivity and potency of a number
of HIV-specific neutralizing against non–clade B isolates than they were against those from …

… neutralization by the human monoclonal antibodies (hmAbs) 80R and S3.1, which can
potently neutralize isolates … .15, potently neutralized GD03 and representative isolates from the …

… We went on to investigate the potency of neutralization by aptamers. In the same PBMC
ID50 system used before, aptamer B4 inhibited HIV-1 Ba-L entry with a 50% inhibitory …

… the neutralization properties of a number of isolates using the panel … evidence of unusually
high neutralizing titers. The viruses … of the isolates indicated above to neutralization by potent …

… MN-rgpl20 is a potent immunogen and … neutralizing a broad range of laboratory and clinical
isolates of HIV-1. These studies demonstrate that susceptibility or resistance to neutralization …

… neutralization of a primary isolate by a MAb or CD4-IgG2, and it is this criterion which we use
below when describing an isolate as ‘‘neutralized’’ … of particularly potent neutralization were …

… Initiative's (IAVI's) Neutralizing Antibody Consortium (6), aimed at screening HIV-1 + subjects
with the goal of identifying individuals with broad and potent neutralizing activities as a …

… First, the classical approach was used in which antibodies were mixed at a constant ratio
that was determined on the basis of their relative neutralization potency (90% inhibitory dose, …